Allentown, PA, United States of America

Michael S Ryan

This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael S Ryan. Retrieved from https://idiyas.com/inventor/michael-s-ryan-i2c9o2al

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael S. Ryan: Innovating Dengue Virus Vaccine Development

Introduction

Michael S. Ryan is a prominent inventor based in Allentown, PA, recognized for his significant contributions to the field of vaccine research, particularly related to dengue virus. With a total of two patents to his name, Ryan's work showcases his commitment to advancing public health through innovative solutions.

Latest Patents

Ryan's latest patents focus on formulations of dengue virus vaccine compositions. These inventions relate to formulations that include at least one live, attenuated dengue virus or chimeric flavivirus, along with various essential components such as buffers, sugars, cellulose derivatives, glycols, or sugar alcohols. Notably, these formulations may also contain alkaline salts and amino acids, highlighting the complex nature of vaccine development.

Career Highlights

Michael S. Ryan currently works at Merck Sharp & Dohme Corporation, a leading pharmaceutical company known for its commitment to developing innovative health solutions. His work in vaccine formulations has potential implications for controlling dengue fever, which is a significant public health issue in many parts of the world. Ryan's dedication to research and development continues to contribute to advancements in medical science.

Collaborations

Throughout his career, Ryan has collaborated with notable coworkers, including Sherrie-Ann P. Martin and Erin J. Green-Trexler. These partnerships are vital in fostering innovative approaches and enhancing the research process within their fields, resulting in more efficient and effective vaccine development.

Conclusion

Michael S. Ryan's contributions to dengue virus vaccine formulation exemplify his role as a leading inventor in the pharmaceutical industry. His innovative work at Merck Sharp & Dohme Corporation and collaborative efforts with fellow researchers highlight the importance of teamwork in advancing public health initiatives. As he continues to innovate, the impact of his inventions may significantly benefit communities worldwide, particularly in combating infectious diseases like dengue fever.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…